Federal Register
Notice: FDA is making available a draft document entitled Guidance for Industry: Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines. It provides recommendations for clinical data to support BLA license approval either as a supplement or as a new BLA using the accelerated approval pathway. Comments should be submitted by 6/8. To download this guidance, click here. To view this notice, click here.